Maribavir
Back to searchMolecule Structure
Scientific Name
Maribavir
Description of the Drug
Maribavir is a cytomegalovirus (CMV) pUL97 kinase inhibitor used for the treatment of refractory post-transplant CMV infection.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB06234
http://www.drugbank.ca/drugs/DB06234
Brand Name(s)
Livtencity
Company Owner(s)
Takeda Pharmaceuticals Usa Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Phosphotransferase pUL97 | SINGLE PROTEIN | INHIBITOR | CHEMBL1287608 |
Serine/threonine-protein kinase BGLF4 | SINGLE PROTEIN | INHIBITOR | CHEMBL3833483 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL791309 | |
DrugBank | DB06234 | |
PubChem: Thomson Pharma | 14804326 | 14853350 |
PubChem | 471161 | |
LINCS | LSM-45590 | |
Nikkaji | J1.159.817J | |
EPA CompTox Dashboard | DTXSID60170091 | |
ChemicalBook | CB6375292 | |
PubChem: Drugs of the Future | 12015036 | |
ZINC | ZINC000003824412 |